A prescription-based comparator supply model replaces bulk forecasting with on-demand dispensing, reducing lead times, waste, and inventory while expanding patient access.
- AI And Predictive Analytics For Clinical Supply Planning
- AI Is Hungry For Data: Does Cross Country Data Make Trials Better?
- Engaging Commercial Supply Chain Professionals Early In Clinical Supply Selection
- Managing Global Programs Across Multiple Stakeholders
- Managing Inbound Supply Risk With R3M In Clinical Supply Chains
- Export Control Risks Hidden In Clinical Supply Workflows
- The Post-American Supply Chain: Navigating The New Multipolar Clinical Landscape
- Building Resilient Clinical Supply Chains In An Era Of Global Disruption
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials
Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.
-
European Clinical Supply Planning – Balancing Cost, Flexibility, And Time
By evaluating the key parameters of a study, sponsors can identify the most effective location for packaging and distributing clinical trial supplies.
-
Biosample Tracking: A Consenting Dilemma
Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.
-
A Smart Solution To Clinical Supply Management
Delve into a solution that ensures the efficient delivery of trial materials worldwide, while navigating the challenges of more complex study designs and the ever-evolving regulatory landscape.
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
Automation Testing In RTSM Software: What Is It And What's The Impact
Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Choosing RTSM? Evaluate The Team Running It, Not Just The Software
High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
Winning The Race To FPI With Early Randomization And Trial Supply Management
Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
How Life Sciences Leaders Are Preparing For More Curveballs In 2026
Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
-
Overcoming The Challenges Of Fragmented Supply Chains
As trials grow more complex, managing clinical supplies is increasingly challenging. In this webinar, experts discussed GxP inventory management and integrated solutions to overcome these hurdles.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.